Low-Dose Mitomycin C as a Prophylaxis for Corneal Haze in Myopic Surface Ablation

American Journal of Ophthalmology

Volumn 144, Issue 5, 2007, Pages

  Thornton, Ivey ^a,b   Puri, Ashok ^c   Xu, Meng ^a   Krueger, Ronald R ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b University of Louisville School of Medicine   (United States)

^c Rajasthan Laser Eye Center   (India)

Author keywords

[No Author keywords available]

Indexed keywords

MITOMYCIN C;

ADULT; ARTICLE; COMPARATIVE STUDY; CORNEA DISEASE; DRUG EFFICACY; EYE SURGERY; FEMALE; FOLLOW UP; HUMAN; INDIA; LASER EPITHELIAL KERATOMILEUSIS; LASER SURGERY; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; MYOPIA; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROPHYLAXIS; RETROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE; UNIVARIATE ANALYSIS; VISUAL ACUITY;

EID: 35348952589     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajo.2007.07.020     Document Type: Article

References (28)

1. Talamo J.H., Gollamudi S., Green W.R., De La Cruz Z., Filatov V., and Stark W.J. Modulation of corneal wound healing after excimer laser keratomileusis using topical mitomycin C and steroids. Arch Ophthalmol 109 (1991) 1141-1146
2. Majmudar P.A., Forstot S.L., Dennis R.F., et al. Topical mitomycin C for subepithelial fibrosis after refractive corneal surgery. Ophthalmology 107 (2000) 89-94
3. Carones F., Vigo L., Scandola E., and Vacchini L. Evaluation of the prophylactic use of mitomycin C to inhibit haze formation after photorefractive keratectomy. J Cataract Refract Surg 28 (2002) 2088-2095
4. Lee J.S., Oum B.S., and Lee S.H. Mitomycin C influence on inhibition of cellular proliferation and subsequent synthesis of type I collagen and laminin in primary and recurrent pterygia. Ophthalmic Res 33 (2001) 140-146
5. Dougherty P.J., Hardten D.R., and Lindstrom R.L. Corneoscleral melt after pterygium surgery using a single intraoperative application of mitomycin C. Cornea 15 (1996) 537-540
6. Safianik B., Ben-Zion I., and Garzozi H.J. Serious corneoscleral complications after pterygium excision with mitomycin C. Br J Ophthalmol 86 (2002) 357-358
7. Rubinfeld R.S., Pfister R.R., Stein R.M., et al. Serious complications of topical mitomycin C after pterygium surgery. Ophthalmology 99 (1992) 1647-1654
8. Chang S.W. Early corneal edema following topical application of mitomycin C. J Cataract Refract Surg 30 (2004) 1742-1750
9. Wu K.Y., Hong S.J., Huang H.T., Lin C.P., and Chen C.W. Toxic effects of mitomycin C on cultured corneal keratocytes and endothelial cells. J Ocul Pharmacol Ther 15 (1999) 401-411
10. Torres R.M., Merayo-Lloves J., Daya S.M., et al. Presence of mitomycin C in the anterior chamber after photorefractive keratectomy. J Cataract Refract Surg 32 (2006) 67-71
11. Morales A.J., Zadok D., Mora-Retana R., Martinez-Gama E., Robledo N.E., and Chayet A.S. Intraoperative mitomycin and corneal endothelium after photorefractive keratectomy. Am J Ophthalmol 142 (2006) 400-404
12. Singh G., Wilson M.R., and Foster C.S. Mitomycin eye drops as treatment for pterygium. Ophthalmology 95 (1988) 813-821
13. Palmer S.S. Mitomycin as adjunct chemotherapy with trabeculectomy. Ophthalmology 98 (1991) 317-321
14. Chang S.W. Corneal keratocyte apoptosis following topical intraoperative mitomycin C in rabbits. J Refract Surg 21 (2005) 446-453
15. Netto M.V., Mohan R.R., Sinha S., Sharma A., Gupta P.C., and Wilson S.E. Effect of prophylactic and therapeutic mitomycin C on corneal apoptosis, proliferation, haze, and long-term keratocyte density. J Refract Surg 22 (2006) 562-574
16. Rajan M.S., O'Brart D.P.S., Patmore A., and Marshall J. Cellular effects of mitomycin C on human corneas after photorefractive keratectomy. J Cataract Refract Surg 32 (2006) 1741-1747
17. Fantes F.E., Hanna K.D., Waring G.O., Pouliquen Y., Thompson K.P., and Savoldelli M. Wound healing after excimer laser keratomileusis (photorefractive keratectomy) in monkeys. Arch Ophthalmol 108 (1990) 665-675
18. Mohan R.R., Hutcheon A.E., Choi R., et al. Apoptosis, necrosis, proliferation, and myofibroblast generation in the stroma following LASIK and PRK. Exp Eye Res 76 (2003) 71-87
19. Argento C., Cosentino M.J., and Ganly M. Comparison of laser epithelial keratomileusis with and without the use of mitomycin C. J Refract Surg 22 (2006) 782-786
20. Sadeghi H.M., Seitz B., Hayashi S., LaBree L., and McDonnell P.J. In vitro effects of mitomycin C on human keratocytes. J Refract Surg 14 (1998) 534-540
21. Schipper I., Suppelt C., and Gebbers J.O. Mitomycin C reduces scar formation after excimer laser (193 nm) photorefractive keratectomy in rabbits. Eye 11 (1997) 649-655
22. Kim T.I., Tchah H., Lee S.A., Sung K., Cho B.J., and Kook M.S. Apoptosis in keratocytes caused by mitomycin C. Invest Ophthalmol Vis Sci 44 (2003) 1912-1917
23. Qazi M.A., Johnson T.W., and Pepose J.S. Development of late-onset subepithelial corneal haze after laser-assisted subepithelial keratectomy with prophylactic intraoperative mitomycin C. Case report and literature review. J Cataract Refract Surg 32 (2006) 1573-1578
24. Netto M.V., Chalita M.R., and Krueger R.R. Corneal haze following PRK with mitomycin C as a retreatment versus prophylactic use in the contralateral eye. J Refract Surg 23 (2007) 96-98
25. Seiler T., Holschbach A., Derse M., et al. Complications of myopic photorefractive keratectomy with the excimer laser. Ophthalmology 101 (1994) 153-160
26. Moller-Pedersen T., Cavanagh H.D., Petroll W.M., and Jester J.V. Corneal haze development after PRK is regulated by volume of stromal tissue removal. Cornea 17 (1998) 627-639
27. Lin N., Yee S.B., Mitra S., et al. Prediction of corneal haze using an ablation depth/corneal thickness ratio after laser epithelial keratomileusis. J Refract Surg 30 (2004) 709-714
28. Vinciguerra P., Camesasca F.I., and Torres I.M. Transition zone design and smoothing in custom laser-assisted subepithelial keratectomy. J Cataract Refract Surg 31 (2005) 39-47